scispace - formally typeset
J

Joan M. Fair

Researcher at Stanford University

Publications -  40
Citations -  5150

Joan M. Fair is an academic researcher from Stanford University. The author has contributed to research in topics: Coronary artery disease & Population. The author has an hindex of 24, co-authored 40 publications receiving 5001 citations.

Papers
More filters
Journal ArticleDOI

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

TL;DR: Intensive multifactor risk reduction conducted over 4 years favorably altered the rate of luminal narrowing in coronary arteries of men and women with coronary artery disease and decreased hospitalizations for clinical cardiac events.
Journal ArticleDOI

American Heart Association Guide for Improving Cardiovascular Health at the Community Level A Statement for Public Health Practitioners, Healthcare Providers, and Health Policy Makers From the American Heart Association Expert Panel on Population and Prevention Science

TL;DR: This Guide for Improving Cardiovascular Health at the Community Level (Community Guide) is intended to provide persons and organizations interested in improving the cardiovascular health of their communities with a comprehensive list of goals, strategies, and recommendations that might be implemented on a community-wide basis.
Journal ArticleDOI

Symptoms of Depression as a Risk Factor for Incident Diabetes: Findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971–1992

TL;DR: An independent role for depressive symptoms in the development of diabetes in populations with low educational attainment is suggested, following adjustment for established diabetes risk factors.
Journal ArticleDOI

Managing abnormal blood lipids: a collaborative approach.

TL;DR: In this article, a multidisciplinary case management approach for patients with abnormal blood lipids (ABL) is described, which encompasses primary and secondary prevention across the lifespan, incorporates nutritional and exercise management as a significant component, defines the importance and indications for pharmacological therapy, and emphasizes the importance of adherence.